No clinical trial has tested castor oil as a treatment for neuropathy, so there is no direct scientific evidence that it works. The interest stems from castor oil’s main fatty acid, ricinoleic acid, which behaves somewhat like capsaicin in laboratory studies and has shown pain-relieving and anti-inflammatory effects in animal models. But a compound showing promise in mice is a long way from a proven treatment for nerve pain in humans, and several practical barriers make the leap from lab to skin even more complicated than usual.
Why Castor Oil Gets Linked to Nerve Pain Relief
Castor oil is roughly 90 percent ricinoleic acid, a fatty acid with an unusual molecular structure. In animal experiments, topical ricinoleic acid reduced pain responses in multiple models of inflammation. Researchers found that it works through a mechanism similar to capsaicin: it interacts with sensory nerve pathways involved in neurogenic inflammation. In mice with chronic inflammatory arthritis, repeated topical treatment with ricinoleic acid increased tolerance to heat pain, and the effect lasted longer than capsaicin’s did.1European Journal of Pharmacology. Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties The same study found that ricinoleic acid lowered levels of substance P, a signaling molecule that amplifies pain messages, in the treated tissue.
This capsaicin parallel is what makes the idea appealing. Capsaicin itself is a proven topical treatment for certain types of neuropathic pain. So if ricinoleic acid acts on similar pathways, maybe castor oil could do something comparable. The catch is that ricinoleic acid has only been studied in animal pain models, not in humans with neuropathy. And as we’ll see, the way castor oil interacts with human skin raises real questions about whether enough ricinoleic acid even reaches the relevant nerve fibers.
The Skin Absorption Problem
For any topical treatment to affect nerve pain, the active ingredient has to penetrate the skin deeply enough to reach sensory nerve endings. A study specifically examining transdermal absorption of castor oil found that it is either poorly absorbed through the skin or is metabolized in a way that does not produce the expected chemical byproducts in the body.2Evidence-Based Integrative Medicine. Transdermal Absorption of Castor Oil This is a significant obstacle. If castor oil largely sits on the skin surface rather than penetrating it, any pain-relieving effects in the underlying nerves would be minimal.
Research on fatty acids as skin penetration enhancers adds another layer of doubt. While some fatty acids are effective at disrupting the skin’s outer barrier and carrying drugs deeper, ricinoleic acid actually performed worse than comparable liquid fatty acids like oleic acid and linoleic acid. Its unusual molecular structure, with a hydroxyl group partway along the carbon chain, appears to limit how well it integrates into the skin’s lipid layers.3PubMed Central. Efficiency of Fatty Acids as Chemical Penetration Enhancers: Mechanisms and Structure Enhancement Relationship So not only does castor oil absorb poorly on its own, its main active component is a relatively weak penetration enhancer compared to other plant-derived fatty acids.
This doesn’t mean castor oil does absolutely nothing when rubbed on the skin. The massage itself, the warmth generated by rubbing, and the moisturizing effect could all provide temporary comfort. But those are generic benefits of any oil massage, not a pharmacological effect specific to castor oil.
What Neuropathic Pain Actually Involves
Understanding why castor oil is unlikely to meaningfully treat neuropathy requires a quick look at what’s actually happening in nerve pain. Neuropathic pain arises from damage to the nervous system itself, whether from diabetes, shingles, chemotherapy, physical injury, or other causes. The damaged nerves become hyperexcitable, firing pain signals without any normal trigger like heat or pressure.4Frontiers in Molecular Neuroscience. Peripheral mechanisms of peripheral neuropathic pain In diabetic neuropathy specifically, sensory neurons develop spontaneous electrical activity that can be measured directly.
The pathology involves changes across many different cell types and signaling systems: altered ion channels, activated immune cells, and shifts in how genes are expressed in nerve tissue.5PubMed. Neuropathic Pain: From Mechanisms to Treatment Pain that starts from peripheral nerve damage can eventually trigger changes in the spinal cord and brain, a process called central sensitization, which makes the pain self-sustaining even after the original injury stabilizes.6PubMed Central. Peripheral Mechanisms of Neuropathic Pain-the Role of Neuronal and Non-Neuronal Interactions and Their Implications for Topical Treatment of Neuropathic Pain
This complexity is why neuropathic pain is notoriously difficult to treat, even with drugs specifically designed for it. A simple anti-inflammatory oil, even one with capsaicin-like properties in animal models, faces long odds against a condition rooted in deep structural changes to the nervous system. The treatments that do work topically for neuropathy succeed because they deliver high concentrations of specific active ingredients directly to peripheral nerve endings.
Topical Treatments That Actually Have Evidence
Two topical treatments are licensed for peripheral neuropathic pain based on rigorous clinical testing: a lidocaine 5% medicated plaster and a capsaicin 8% patch. The capsaicin 8% patch performed as well as pregabalin, a widely used oral medication, across several types of peripheral neuropathic pain in a head-to-head trial, and both topical options caused fewer of the systemic side effects that oral pain drugs are known for.7Journal of Pain and Symptom Management. Topical Treatment of Peripheral Neuropathic Pain: Applying the Evidence
The capsaicin connection is worth pausing on. Low-dose capsaicin creams, the kind you can buy over the counter, have not shown strong results for neuropathic pain. It’s the high-dose 8% patch, applied by a healthcare provider in a clinical setting, that produces meaningful relief for conditions like post-herpetic neuralgia.8PubMed Central. Capsaicinoids in the treatment of neuropathic pain: a review This matters because even if ricinoleic acid truly mimics capsaicin’s mechanism, it would need to reach nerve endings in very high concentrations to replicate what the 8% capsaicin patch achieves. A casual application of castor oil is unlikely to deliver anything close to that concentration at the relevant tissue depth. A narrative review of topical treatments for diabetic neuropathy confirmed that 8% capsaicin patches and 5% lidocaine patches had the most supporting evidence, along with some data for topical clonidine, gabapentin, and amitriptyline.9PubMed Central. Assessing the efficacy of topical formulations in diabetic neuropathy: a narrative review Castor oil did not appear anywhere in these reviews.
The Substance P Connection
One of the more compelling findings from animal research is that ricinoleic acid depletes substance P in treated tissue.1European Journal of Pharmacology. Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties Substance P is a neuropeptide that transmits and amplifies pain signals. Capsaicin works partly by overwhelming the nerve fibers that release substance P, eventually depleting their stores so they can no longer send pain messages as effectively. This is why capsaicin initially causes a burning sensation before the pain-relieving effect kicks in.
Ricinoleic acid appears to do something similar without the initial burning.10PubMed Central. Effect of ricinoleic acid in acute and subchronic experimental models of inflammation In theory, that’s a real advantage: one of the biggest barriers to capsaicin therapy is that patients can’t tolerate the pain during application. A compound that depletes substance P without causing intense irritation would be genuinely useful. But this has only been demonstrated by injecting ricinoleic acid directly into tissue in animal models, not by applying castor oil to human skin. The gap between direct tissue injection in a mouse and casual topical application in a person is enormous.
Historical Claims and Their Limits
Castor oil has been used in folk medicine for centuries, and the idea that it might help with nerve pain isn’t entirely new. A report from 1900 described a physician’s experience treating facial neuralgia with castor oil, claiming that thirteen consecutive patients who had been scheduled for surgery were “relieved, or greatly improved” by its use.11JAMA. CASTOR-OIL IN THE TREATMENT OF NEURALGIA This is a fascinating historical footnote, but it is an uncontrolled case series from over a century ago. Pain conditions, and especially facial neuralgia, are strongly influenced by placebo effects, spontaneous remission, and the natural fluctuation of symptoms over time. Without a comparison group, these results are impossible to interpret reliably.
That said, the fact that doctors were reporting positive experiences with castor oil for nerve pain more than 120 years ago is at least consistent with the modern laboratory findings about ricinoleic acid’s capsaicin-like activity. The animal research didn’t come out of nowhere. There’s a long, informal tradition suggesting something is happening when castor oil contacts painful tissue. The problem is that “something is happening” is very different from “this is an effective treatment,” and no one has run the kinds of controlled trials needed to bridge that gap.
Safety Considerations for Topical Use
Castor oil is generally considered safe for skin application, but it’s not completely without risk. The most reported adverse reaction is allergic contact dermatitis. Case reports describe patients developing skin inflammation from cosmetic and hygiene products containing castor oil, with reactions ranging from localized rashes to more widespread angioedema-like swelling.12PubMed Central. Use of Castor Oil in Dermatology: A Narrative Review In one case, a woman developed persistent lip darkening and swelling over more than a year from ricinoleic acid in lipstick products. In another, a patient developed facial swelling and hive-like lesions within hours of using an ear-care product containing castor oil.
The evidence points to ricinoleic acid as the main sensitizing component. In patch-testing studies, patients with castor oil allergies reacted to non-hydrogenated castor oil (which contains ricinoleic acid) but not to hydrogenated forms (which don’t).13PubMed. Allergic axillary dermatitis due to hydrogenated castor oil in a deodorant These reactions are uncommon in the general population, but for someone already dealing with neuropathic pain, adding an allergic skin reaction on top would make things worse.
People with diabetic neuropathy face an additional concern. Reduced sensation in the feet means you may not notice early signs of an allergic reaction, skin breakdown, or irritation from repeated oil application. Diabetic skin is already more vulnerable to infection and slow healing. While one trial found that topical olive oil safely improved superficial diabetic foot ulcer healing,14Diabetes & Metabolic Syndrome: Clinical Research & Reviews. The effect of topical olive oil dressing on the healing of grade 1 and 2 diabetic foot ulcers castor oil has not been studied in this context, and the two oils have different compositions. Anyone with diabetes should be cautious about applying any unproven topical product to areas with compromised sensation.
What About Ricin?
A common question when castor oil comes up is whether it contains ricin, the infamous toxin found in castor beans. Commercial castor oil does not contain ricin. The heat and pressure used during oil extraction denatures the protein, rendering it inactive.15Industrial Crops and Products. Degradation of ricin in castor seed meal by temperature and chemical treatment Refined castor oil sold for cosmetic or pharmaceutical use has been processed to remove any traces. This is not a safety concern for topical use.
The Counter-Irritation Factor
Some of the perceived benefit when people rub castor oil on painful areas may come from counter-irritation, a well-documented pain relief mechanism that has nothing to do with the specific oil being used. When you stimulate the skin with massage, warmth, or mild chemical stimulation, sensory nerve fibers carry those signals to the spinal cord, where they can partially block pain transmission from deeper structures. Menthol-based products work this way, initially stimulating skin receptors and then desensitizing them.16PubMed. The role and mechanism of action of menthol in topical analgesic products
Castor oil is thick and viscous, making it feel distinctly different from lighter oils when rubbed into the skin. That tactile experience, combined with the warmth generated by massage and the general comfort of having a painful area attended to, could easily produce a temporary sense of relief that gets attributed to the oil itself. This isn’t a trivial effect: counter-irritation and massage genuinely do modulate pain perception. But you could achieve the same thing with coconut oil, olive oil, or an unscented lotion. The relief, to whatever extent it occurs, isn’t specific to castor oil’s pharmacological properties.
Where Ricinoleic Acid Research Stands
The honest assessment is that ricinoleic acid is an interesting compound that has shown genuine biological activity in controlled laboratory and animal settings. Its ability to reduce pain responses and deplete substance P without causing the intense burning of capsaicin makes it a plausible candidate for further drug development.10PubMed Central. Effect of ricinoleic acid in acute and subchronic experimental models of inflammation But “plausible candidate” is a stage of research, not a recommendation. Many compounds that work in mice never prove effective in humans. Many that work when injected directly into tissue fail when applied to intact skin.
For ricinoleic acid to become a real neuropathy treatment, researchers would need to solve the skin penetration problem, likely by formulating it into a specialized delivery system rather than just using raw castor oil. Then they would need to test that formulation in clinical trials against placebo and against existing treatments like the capsaicin 8% patch. None of that work has been done. Until it is, recommending castor oil for neuropathy means recommending something based on a chain of reasoning (“it’s like capsaicin, and capsaicin works, so maybe it works too”) rather than on evidence that the end product actually helps people with nerve pain.
If you’re dealing with neuropathic pain and want to explore topical options, the treatments with actual human evidence behind them are the capsaicin 8% patch and lidocaine 5% plaster, both of which require a prescription or clinical application. Over-the-counter capsaicin creams at lower concentrations have weaker evidence but are at least studied in the relevant condition. Castor oil, despite its long folk-medicine history and some genuinely interesting lab science, remains in the category of “might do something, but we don’t know.”